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Figure 1. K-M curve showing outcome out to 3 years
Conclusion: In patients requiring stenting of large coronary arteries during primary
PCI, there was reduced MACE in patients treated with DES. This benefit was primarily
driven by decreased target vessel revascularisation.
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Background: Limited data are available on the predictors and implications of
gastrointestinal (GI) bleeding in ST-elevation Myocardial infarction (STEMI) patients,
whose contemporary management includes a combination of anticoagulation and
double or triple antiplatelet therapy. Therefore we assessed the predictors and
prognostic value for one year mortality of GI bleedings in STEMI patients.
Methods: We analyzed the occurrence of a GI bleeding within 1 year from the index
procedure, in 1762 consecutive STEMI patients undergoing pPCI between 1-1-2003
and 31-8-2008, in a large tertiary PCI center. Bleeding and bleeding source were
recorded from chart review. A GI bleeding was defined as an episode of hematemesis,
melena or red blood loss per rectum with a haemoglobin decrease ≥ 3 g/dL. Predictors
of GI bleeding were calculated using a stepwise logistic regression analysis. The
prognostic values of a GI bleeding for one-year mortality was calculated using a
stepwise Cox proportional Hazards models treating the development of a GI bleeding
as time-dependant covariate, including the following candidate covariables: age, sex,
history of diabetes, hypertension, hypercholesterolemia, current smoking, prior PCI,
prior CABG, previous MI, baseline creatinin clearance, baseline Hb, heart rate and
systolic blood pressure, shock, peak CK-MB release and multivessel disease.
Results: 39 (2.2%) patients suffered a GI bleeding within one year. Predictors of GI
bleeding were age (OR 1.07, 95% CI 1.04 – 1.11, p < 0.001), current smoker (OR 2.71,
95% CI 1.25 – 5.90, p = 0.012), previous CABG (OR 4.81, 95% CI 1.64 – 14.1, p =
0.004), shock (OR 2.59, 1.06 – 6.32, p = 0.037) and the use of GP IIb/IIIa inhibitor
(OR 2.58, 95% CI 1.27 – 5.24, p = 0.009). After adjustment for other predictors of one
year mortality in a time-dependant model, GI bleeding was associated with a
statistically significant higher risk for one year mortality: HR 2.69 (1.16 – 6.26, p =
0.019).
Conclusion: GI bleeding in the setting of STEMI is independently associated with
increased one-year mortality.
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Background: The aim of this study was to investigate the effects of early peripheral
mobilization of stem cells with pluripotency gene expression on cardiovascular events
in patients with ST-elevation myocardial infarction (STEMI) during the 4-year follow-
up.
Methods: Peripheral blood mononuclear cells (PBMCs) were isolated on days 0, 1
and 7 from patients with STEMI (n=40) and healthy controls (n=20). The numbers of
CD34+, CD117+, CD133+ and c-met+ stem cells were measured by flow-cytometry,
and PBMCs were analyzed by real-time PCR for Oct-4 and Nanog gene expressions.
The plasma concentrations of CRP, IL-6, SCF, SDF-1 and VEGF were measured with
ELISA kits. Major adverse cardiovascular events (MACEs) such as non-fatal MI,
death, stroke, target lesion revascularization were observed during the 4-year follow-
up.
Results: MACEs were significantly lower in patients with Oct-4 gene expression ≥
1.13 and Nanog gene expression ≥ 1.20 on admission (Table 1). The numbers of
CD34+, CD117+, CD133+ and c-met+ cells within 7 days after AMI did not show
significant differences in patients with or without MACE. Anti-inflammatory marker
such as IL-10 was significantly higher within 7 days after AMI in patients without
MACE. Inflammatory and angiogenic markers such as CRP, IL-6, SCF, SDF-1, and
VEGF did not show significant differences in patients with or without MACE.
Conclusion: mRNA levels of pluripotent embryonic stem markers such as Oct-4 and
Nanog were significantly higher in AMI patients without MACE during the 4-year
follow-up. Baseline Oct-4 and Nanog gene expression levels could be used as
predictors of MACE in STEMI patients.
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Background: Thromboaspiration (TA) during primary percutaneous intervention
(PPCI) is effective in opening the infarct-related artery in patients with ST-segment
elevation myocardial infarction (STEMI), leading to better reperfusion and improved
outcome. However, the effect of positive macroscopic efficiency of TA remains
unknown. We aimed to evaluate the impact of positive thrombus retrieval during PPCI
with manual TA on infarct size (IS), microvascular obstruction (MVO) and left
ventricular (LV) remodeling as assessed by contrast-enhanced magnetic resonance
imaging (CE-MRI) in a subset of patients with STEMI.
Methods: Inclusion criteria were patients aged <75 years, with STEMI referred for
PPCI within 12 hours of onset of symptoms, infarct-related artery ≥2.5 mm in diameter,
thrombus score ≥3 and no prior history of coronary disease. All patients underwent TA
before stenting and were categorized according to positive or negative TA. Clinical
and procedural characteristics of study population were recorded and CE-MRI was
performed at 5 days and 6-months to evaluate IS, MVO and LV remodeling as assessed
by LV volumes.
Results: 73 patients were enrolled, mean age 55±10 years; 39.7% in the positive TA
group. Main results are presented in the table. Clinical and procedural characteristics
(90-min total ischemic time, ST-segment resolution, post-procedural TIMI flow grade
and post-stenting myocardial blush grade, and peak troponin) did not differ
significantly between groups.
LVSVI = left ventricular stroke volume index
Conclusion: Positive thrombus retrieval during primary PPCI with manual TA in
STEMI reduces IS at 5 day and 6 months, reduces MVO and improves LV remodeling.
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